Unrelated Donor Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed and Refractory Hodgkin Lymphoma-Reference-Cited by-同舟云学术

Unrelated Donor Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed and Refractory Hodgkin Lymphoma

Published:2009-01 Issue:1 Volume:15 Page:109-117
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Devetten Marcel P.,Hari Parameswaran N.,Carreras Jeanette,Logan Brent R.,van Besien Koen,Bredeson Christopher N.,Freytes César O.,Gale Robert Peter,Gibson John,Giralt Sergio A.,Goldstein Steven C.,Gupta Vikas,Marks David I.,Maziarz Richard T.,Vose Julie M.,Lazarus Hillard M.,Anderlini Paolo

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference29 articles.

1. Problems in Hodgkin disease management;Aisenberg;Blood,1999

2. Autologous hematopoietic cell transplantation in non-Hodgkin lymphoma;Johnston;Hematol Oncol Clin North Am,1999

3. Prognostic factors and treatment outcome in primary progressive Hodgkin lymphoma: a report from the German Hodgkin Lymphoma Study Group;Josting;Blood,2000

4. Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin disease: a randomised trial;Schmitz;Lancet,2002

5. High-dose sequential chemotherapy and peripheral blood progenitor cell autografting in patients with refractory and/or recurrent Hodgkin lymphoma

Cited by 90 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of transplantation in Hodgkin lymphoma;Frontiers in Oncology;2023-01-26

2. Outcomes associated with allogeneic hematopoietic stem cell transplantation for relapsed and refractory Hodgkin lymphoma in the era of novel agents;Cancer Medicine;2023-01-18

3. Filling the Gap: The Immune Therapeutic Armamentarium for Relapsed/Refractory Hodgkin Lymphoma;Journal of Clinical Medicine;2022-11-06

4. A Cure Rate Survival Model after Stem Cell Transplantation for Relapsed or Refractory Hodgkin Lymphoma Patients;MIDDLE EAST J CANCER;2022

5. Reappraising the Role of Allogeneic Hematopoietic Stem Cell Transplantation in Relapsed and Refractory Hodgkin’s Lymphoma: Recent Advances and Outcomes;Journal of Personalized Medicine;2022-01-18